Citius Pharmaceuticals, Inc.

CTXR·NasdaqCM·Healthcare
Compare
0.5510−0.0222 (−3.87%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.5732
Open0.5620
Day range0.54220.5708
52-week range0.37001.5400
Off day high−3.47%
Off 52-week high−64.22%
Volume138.08K
Avg. volume (3M)470.21K
Market cap15.13M
EPS (TTM)-1.75
Forward P/E-0.38
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.04
Shares outstanding27.45M
Short interest21.14% of float
Earnings dateDec 29, 2026 (est.)
Analyst target4.0000
Profit margin0.00%

Against its peers

Compare in full ›
CTXR LSTA ET80.F PMCB CNSP HRTX
Market cap 15.13M 11.45M 5.30M 4.09M 6.34M 56.69M
P/E (TTM) — — — — — —
Forward P/E -0.4 -0.9 — -1.0 -11.1 -2.7
Price/book 0.2 1.2 0.4 0.1 0.3 9.6
Dividend yield — — — — — —
1-year change −58.18% −53.42% −16.51% −61.58% −33.30% −74.77%
Today −3.87% −2.75% +0.95% +12.03% −4.62% +4.88%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CTXR news ›
Defense World·Positive

Analyzing Citius Oncology (CTOR) and Its Rivals

Posted by Defense World Staff on Oct 31st, 2026 Citius Oncology (NASDAQ:CTOR – Get Free Report) is one of 844 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare…

Markets Daily··2 outlets

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Stock Now Rated “Hold” by Sell-Side Brokerages

Posted by Sarita Garza on Oct 15th, 2026 Check Out Our Latest Analysis on CTXR Citius Pharmaceuticals (NASDAQ:CTXR – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.34)…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

7mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance